Felix Seyfried

449 total citations
16 papers, 145 citations indexed

About

Felix Seyfried is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Felix Seyfried has authored 16 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Felix Seyfried's work include Acute Lymphoblastic Leukemia research (11 papers), Cell death mechanisms and regulation (5 papers) and Cancer therapeutics and mechanisms (4 papers). Felix Seyfried is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Cell death mechanisms and regulation (5 papers) and Cancer therapeutics and mechanisms (4 papers). Felix Seyfried collaborates with scholars based in Germany, Italy and Spain. Felix Seyfried's co-authors include Klaus‐Michael Debatin, Lüder Hinrich Meyer, Luca Trentin, Salih Demir, Johann M. Kraus, Julia Herzig, Stephan Stilgenbauer, Manon Queudeville, Rolf Köhler and Melanie Schirmer and has published in prestigious journals such as Blood, Leukemia and Cell Death and Disease.

In The Last Decade

Felix Seyfried

13 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Seyfried Germany 6 74 45 44 38 37 16 145
André Bortolini Silveira Brazil 5 69 0.9× 39 0.9× 35 0.8× 24 0.6× 28 0.8× 5 120
Shlomzion Aumann Israel 7 97 1.3× 25 0.6× 53 1.2× 33 0.9× 51 1.4× 25 160
Stefan Köhrer Austria 4 69 0.9× 22 0.5× 32 0.7× 41 1.1× 42 1.1× 11 153
Naïs Prade France 5 35 0.5× 19 0.4× 42 1.0× 37 1.0× 31 0.8× 8 138
Maria Chiara Abbenante Italy 7 80 1.1× 66 1.5× 83 1.9× 45 1.2× 45 1.2× 27 173
Pilar Martínez‐Sánchez Spain 7 50 0.7× 18 0.4× 69 1.6× 24 0.6× 58 1.6× 18 129
Maria López‐Pavía Spain 9 102 1.4× 31 0.7× 108 2.5× 31 0.8× 21 0.6× 21 183
Mays Jawad United Kingdom 8 109 1.5× 30 0.7× 88 2.0× 20 0.5× 35 0.9× 13 187
Frédéric Davi France 4 41 0.6× 102 2.3× 88 2.0× 39 1.0× 42 1.1× 6 180
Astrid Novosel Germany 4 99 1.3× 43 1.0× 27 0.6× 16 0.4× 21 0.6× 5 162

Countries citing papers authored by Felix Seyfried

Since Specialization
Citations

This map shows the geographic impact of Felix Seyfried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Seyfried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Seyfried more than expected).

Fields of papers citing papers by Felix Seyfried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Seyfried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Seyfried. The network helps show where Felix Seyfried may publish in the future.

Co-authorship network of co-authors of Felix Seyfried

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Seyfried. A scholar is included among the top collaborators of Felix Seyfried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Seyfried. Felix Seyfried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bergmann, Anke K., Martin Zimmermann, Gunnar Cario, et al.. (2025). Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax. Leukemia. 39(6). 1520–1525.
2.
Enzenmüller, Stefanie, Felix Seyfried, Daniel Tews, et al.. (2024). Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation. Cell Death and Disease. 15(7). 475–475. 3 indexed citations
3.
Knoll, Maximilian, Deyan Y. Yosifov, Christof Schneider, et al.. (2024). Biallelic Deletion 13q in Chronic Lymphocytic Leukemia Treated with Targeted Agents. Blood. 144(Supplement 1). 4608–4608.
4.
Bender, Johanna, et al.. (2024). The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL. Blood Advances. 8(23). 6035–6042. 1 indexed citations
5.
6.
Zabrocki, Piotr, et al.. (2023). P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. HemaSphere. 7(S3). e6339407–e6339407.
7.
Menéndez, Pablo, Manuel Ramı́rez, Felix Seyfried, et al.. (2021). MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia. Frontiers in Cell and Developmental Biology. 9. 695225–695225. 6 indexed citations
8.
Jebaraj, Billy Michael Chelliah, Philipp M. Roessner, Felix Seyfried, et al.. (2021). Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia. Blood. 139(6). 859–875. 23 indexed citations
9.
Seyfried, Felix, Eugen Tausch, Johannes Bloehdorn, et al.. (2019). Venetoclax Resistance in Mantle Cell Lymphoma Is Mediated By BCL-XL and Can be Circumvent By Inhibiting the BH4 Domain of BCL-2. Blood. 134(Supplement_1). 1507–1507. 1 indexed citations
10.
Trentin, Luca, Manon Queudeville, Elena Boldrin, et al.. (2018). Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic state. Haematologica. 103(6). 1008–1017. 4 indexed citations
11.
Wang, Fan, Salih Demir, Felix Seyfried, et al.. (2018). Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia. Blood. 131(26). 2929–2942. 24 indexed citations
12.
Trentin, Luca, Julia Herzig, Salih Demir, et al.. (2017). Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. Blood. 130(5). 643–654. 48 indexed citations
13.
Schirmer, Melanie, Luca Trentin, Manon Queudeville, et al.. (2016). Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia. Cell Death and Disease. 7(1). e2052–e2052. 19 indexed citations
14.
15.
Seyfried, Felix, et al.. (2015). Synergistic Activity of ABT-199 with Conventional Chemotherapy and Dinaciclib in B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 126(23). 2631–2631. 1 indexed citations
16.
Queudeville, Manon, Felix Seyfried, Luca Trentin, et al.. (2012). Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling. Cell Death and Disease. 3(8). e364–e364. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Bortolini Silveira Breakdown of academic impact, for papers by Shlomzion Aumann Breakdown of academic impact, for papers by Stefan Köhrer Breakdown of academic impact, for papers by Naïs Prade Breakdown of academic impact, for papers by Maria Chiara Abbenante Breakdown of academic impact, for papers by Pilar Martínez‐Sánchez Breakdown of academic impact, for papers by Maria López‐Pavía Breakdown of academic impact, for papers by Mays Jawad Breakdown of academic impact, for papers by Frédéric Davi Breakdown of academic impact, for papers by Astrid Novosel
Rankless by CCL
2026